ReviewImmunoTargets and therapy2014

Emerging treatments in management of prostate cancer: biomarker validation and endpoints for immunotherapy clinical trial design.

Susan F SlovinPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.